Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

JAK Inhibitor Dose TAPering Strategy Study in Low Disease Activity Rheumatoid Arthritis Patients

NCT06687551 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06687551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
JAK Inhibitor Dose TAPering Strategy Study in Low Disease Activity Rheumatoid Arthritis Patients
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Recruiting
Start date
June 6, 2025
Completion date
April 1, 2029
Enrollment
308 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra